I think all long shareholders are frustrated that we’re still waiting on some type of approval to generate revenue, but I would call one of these “firms” to join a class action lawsuit. Nader should of been more upfront about the original EUA for m/m but signals do get crossed at times in business and in the grand scheme I don’t think that 1 event was the catalyst to many of us losing 6 figures. I think he tries to share too much information at times and that can be a gift and a curse to a pre revenue bio company. We’re hear for the science and we’ll prevail because of the science and also because NP doesn’t stop pushing forward, even though he does fumble from time to time.